Ceeto Capital Group LLC Sells 1,358 Shares of CVS Health Co. (NYSE:CVS)

Ceeto Capital Group LLC lessened its stake in CVS Health Co. (NYSE:CVS) by 5.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 22,596 shares of the pharmacy operator’s stock after selling 1,358 shares during the period. Ceeto Capital Group LLC’s holdings in CVS Health were worth $1,802,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Riverpoint Wealth Management Holdings LLC bought a new stake in shares of CVS Health in the fourth quarter valued at about $218,000. Canoe Financial LP lifted its stake in shares of CVS Health by 95.1% in the fourth quarter. Canoe Financial LP now owns 1,762,629 shares of the pharmacy operator’s stock valued at $139,177,000 after buying an additional 859,134 shares during the period. Meritage Portfolio Management lifted its stake in CVS Health by 30.6% during the fourth quarter. Meritage Portfolio Management now owns 66,322 shares of the pharmacy operator’s stock worth $5,237,000 after purchasing an additional 15,548 shares during the period. Steph & Co. lifted its stake in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the period. Finally, Forum Financial Management LP lifted its stake in CVS Health by 19.4% during the fourth quarter. Forum Financial Management LP now owns 17,856 shares of the pharmacy operator’s stock worth $1,410,000 after purchasing an additional 2,901 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on CVS shares. Baird R W upgraded shares of CVS Health to a “hold” rating in a research note on Thursday, May 30th. Wells Fargo & Company cut their price target on shares of CVS Health from $76.00 to $60.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 7th. Cantor Fitzgerald restated a “neutral” rating and set a $58.00 price target on shares of CVS Health in a research note on Tuesday, July 23rd. JPMorgan Chase & Co. dropped their price objective on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Finally, Mizuho dropped their price objective on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating for the company in a report on Thursday, May 2nd. Eleven investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and an average target price of $75.05.

Insider Transactions at CVS Health

In other news, Director Edward J. Ludwig purchased 1,000 shares of CVS Health stock in a transaction dated Thursday, May 2nd. The shares were bought at an average cost of $53.88 per share, with a total value of $53,880.00. Following the completion of the transaction, the director now directly owns 21,630 shares in the company, valued at approximately $1,165,424.40. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 0.24% of the company’s stock.

CVS Health Trading Up 4.0 %

CVS traded up $2.35 during trading on Friday, reaching $61.00. 14,553,173 shares of the company’s stock were exchanged, compared to its average volume of 7,959,074. The company’s fifty day moving average price is $58.85 and its 200-day moving average price is $67.30. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.61 and a current ratio of 0.81. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The firm has a market capitalization of $76.58 billion, a PE ratio of 10.72, a P/E/G ratio of 0.58 and a beta of 0.52.

CVS Health (NYSE:CVS) last released its earnings results on Wednesday, May 1st. The pharmacy operator reported $1.31 EPS for the quarter, missing analysts’ consensus estimates of $1.69 by ($0.38). CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The business had revenue of $88.44 billion for the quarter, compared to analyst estimates of $89.33 billion. During the same period in the prior year, the firm posted $2.20 EPS. CVS Health’s revenue was up 3.7% on a year-over-year basis. As a group, equities analysts forecast that CVS Health Co. will post 7 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Monday, July 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.36%. CVS Health’s dividend payout ratio is 46.75%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.